What do systematic reviews say?

DPP4i vs placebo

DPP4i showed no clear difference in stroke (fatal or non‐fatal) compared with placebo (high certainty).

• Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2… 2021 · Cochrane Headline outcomes only
  OR 1 [0.87, 1.14]
  5 studies · 42588 participants
  High